You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PFIZERPEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pfizerpen patents expire, and when can generic versions of Pfizerpen launch?

Pfizerpen is a drug marketed by Pfizer and is included in eight NDAs.

The generic ingredient in PFIZERPEN is penicillin g procaine. There are ninety-two drug master file entries for this compound. Additional details are available on the penicillin g procaine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pfizerpen

A generic version of PFIZERPEN was approved as penicillin g procaine by KING PHARMS LLC on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PFIZERPEN?
  • What are the global sales for PFIZERPEN?
  • What is Average Wholesale Price for PFIZERPEN?
Drug patent expirations by year for PFIZERPEN
Drug Prices for PFIZERPEN

See drug prices for PFIZERPEN

Pharmacology for PFIZERPEN

US Patents and Regulatory Information for PFIZERPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer PFIZERPEN penicillin g potassium INJECTABLE;INJECTION 060657-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer PFIZERPEN-A ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 062049-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer PFIZERPEN G penicillin g potassium TABLET;ORAL 060075-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer PFIZERPEN G penicillin g potassium FOR SOLUTION;ORAL 060587-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer PFIZERPEN VK penicillin v potassium FOR SOLUTION;ORAL 061815-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.